Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol

NCT00706680 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Graft Rejection

Interventions

DRUG: Thymoglobulin

Sponsor

University Health Network, Toronto

Collaborators

[object Object]
[object Object]
[object Object]